InvestorsHub Logo

stervc

06/28/17 12:09 PM

#66239 RE: JPS02 #66140

Important AMS & BLDV Clarification…

I think it’s important to add some clarification regarding AMS and BLDV after doing a little more research.

The Funder that’s giving up the $12 Million is doing so to fund AMS and not BLDV. Of course, with AMS coming in under BLDV as a wholly owned subsidiary, there will be some huge benefit for BLDV with this funding being completed because AMS moving forward will benefit BLDV. I think people are mixing the two. The Funder probably barely even knows or even cares about BLDV. The Funder primary concern is to fund AMS. AMS will be responsible for paying back the $12 Million and not BLDV. Like what was mentioned by Josh, within the conference call, this will not be a BLDV debt. It must be considered two separate mindsets of thoughts.

The AMS project itself is considered the collateral. The Funder is simply greatly believing in the AMS project in Canada to cultivate cannabis/marijuana which is why the Funder is willing to give AMS the $12 Million. The strength of this belief came about because of the Funder verifying with Health Canada that AMS is actually at Step 6 with obtaining its marijuana cultivation license approval from Health Canada.

AMS will pay the Funder back the $12 million plus interest from the Revenues to be generated. AMS already have relationships with pharmaceutical companies as clientele in place to support their marijuana cultivation in Canada whom will buy product and products from AMS. They also have huge plans for expansion in place. After a year and since the AMS project is expected to be fully operational by then, AMS is then expected to exercise its right to refinance its operations by using their completed facility as collateral to remove the current Funder from the equation. They will pay the Funder back its money with interest then AMS will become their own Funder by funding its own operations.

AMS is at Step 6 with Health Canada for some very substantial reasons that investors are not aware of just yet, but will learn of these reasons after this phase of financing is completed in my opinion. I think people are underestimating the achievements that have been completed thus far by AMS and BLDV.

v/r
Sterling